ATEZOLIZUMAB

39719 reported adverse events

Drug classes: Programmed Death Receptor-1 Blocking Antibody [EPC]

These side effects are most commonly reported by patients taking ATEZOLIZUMAB:

# Side effect Count
0 DEATH 4361
1 OFF LABEL USE 3721
2 DISEASE PROGRESSION 2260
3 PYREXIA 1803
4 DIARRHOEA 1750
5 FATIGUE 1560
6 ANAEMIA 1387
7 PNEUMONIA 1160
8 DECREASED APPETITE 1143
9 HYPOTHYROIDISM 1132
See all common reactions for ATEZOLIZUMAB

ATEZOLIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYSTEMIC IMMUNE ACTIVATION 26 0.4906
1 MIXED HEPATOCELLULAR CHOLANGIOCARCINOMA 22 0.4889
2 PHARYNGEAL NECROSIS 13 0.2826
3 ALPHA 1 FOETOPROTEIN DECREASED 11 0.2750
4 PARANEOPLASTIC NEUROLOGICAL SYNDROME 35 0.2734
5 REACTIVE CAPILLARY ENDOTHELIAL PROLIFERATION 15 0.2727
6 TUMOUR FISTULISATION 12 0.2000
7 SMALL CELL LUNG CANCER RECURRENT 11 0.1930
8 ENDOCRINE TOXICITY 19 0.1863
9 TUMOUR THROMBOSIS 38 0.1667
See all enriched reactions for ATEZOLIZUMAB